Hillier Sharon, Roberts Zoe, Dunstan Frank, Butler Chris, Howard Anthony, Palmer Stephen
Department of Epidemiology, Centre for Health Sciences Research, Cardiff University, Neuadd Meirionydd, Heath Park, Cardiff CF14 4YS, UK.
J Antimicrob Chemother. 2007 Jul;60(1):92-9. doi: 10.1093/jac/dkm141. Epub 2007 May 30.
To assess the effect of previous antibiotic use on the risk of a resistant Escherichia coli urinary tract infection (UTI), we undertook a case-control study with prospective measurement of outcomes in 10 general practices in the UK.
Urinary samples from all patients with symptoms suggestive of UTIs were sought, and those with a laboratory-proven E. coli infection were interviewed and their medical records examined. Case patients were those with ampicillin- or trimethoprim-resistant infections and control patients had infections that were susceptible to antibiotics, including ampicillin and trimethoprim.
Risk of ampicillin-resistant E. coli infection in 903 patients was associated with amoxicillin prescriptions of >or=7 days duration in the previous 1 month [odds ratio (OR)=3.91, 95% CI 1.64-9.34] and previous 2-3 months (2.29, 1.12-4.70) before illness onset. For prescriptions <7 days duration, there was no statistically significant association. Higher doses of amoxicillin were associated with lower risk of ampicillin resistance. For trimethoprim-resistant E. coli infections, the OR was 8.44 (3.12-22.86) for prescriptions of trimethoprim of >or=7 days in the previous month and 13.91 (3.32-58.31) for the previous 2-3 months. For trimethoprim prescriptions of <7 days, the OR was 4.03 (1.69-9.59) for the previous month but prescribing in earlier periods was not significantly associated with resistance.
Within the community setting, exposure to antibiotics is a strong risk factor for a resistant E. coli UTI. High-dose, shorter-duration antibiotic regimens may reduce the pressure on the emergence of antibiotic resistance.
为评估既往使用抗生素对耐甲氧西林大肠杆菌尿路感染(UTI)风险的影响,我们在英国的10家普通诊所开展了一项病例对照研究,并对结局进行前瞻性测量。
收集所有有UTI症状患者的尿液样本,对那些经实验室证实为大肠杆菌感染的患者进行访谈并检查其病历。病例患者为感染对氨苄西林或甲氧苄啶耐药的患者,对照患者的感染对包括氨苄西林和甲氧苄啶在内的抗生素敏感。
903例患者中,氨苄西林耐药大肠杆菌感染的风险与发病前1个月内阿莫西林处方持续时间≥7天相关[比值比(OR)=3.91,95%置信区间1.64 - 9.34],以及发病前2 - 3个月(2.29,1.12 - 4.70)。对于处方持续时间<7天的情况,无统计学显著关联。较高剂量的阿莫西林与较低的氨苄西林耐药风险相关。对于甲氧苄啶耐药大肠杆菌感染,上个月甲氧苄啶处方持续时间≥7天的OR为8.44(3.12 - 22.86),前2 - 3个月为13.91(3.32 - 58.31)。对于上个月甲氧苄啶处方持续时间<7天的情况,OR为4.03(1.69 - 9.59),但早期处方与耐药无显著关联。
在社区环境中,接触抗生素是耐甲氧西林大肠杆菌UTI的一个重要危险因素。高剂量、短疗程的抗生素治疗方案可能会降低抗生素耐药性出现的压力。